NO20033433D0 - Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol - Google Patents

Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol

Info

Publication number
NO20033433D0
NO20033433D0 NO20033433A NO20033433A NO20033433D0 NO 20033433 D0 NO20033433 D0 NO 20033433D0 NO 20033433 A NO20033433 A NO 20033433A NO 20033433 A NO20033433 A NO 20033433A NO 20033433 D0 NO20033433 D0 NO 20033433D0
Authority
NO
Norway
Prior art keywords
pyridylmethyl
sulfinyl
benzimidazole
preparation
Prior art date
Application number
NO20033433A
Other languages
English (en)
Other versions
NO20033433L (no
Inventor
Ilya Avrutov
Marioara Mendelovici
Original Assignee
Teva Pharmaceutical Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Usa Inc filed Critical Teva Pharmaceutical Usa Inc
Publication of NO20033433D0 publication Critical patent/NO20033433D0/no
Publication of NO20033433L publication Critical patent/NO20033433L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20033433A 2001-02-02 2003-08-01 Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol NO20033433L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26616201P 2001-02-02 2001-02-02
PCT/US2002/003225 WO2002062786A1 (en) 2001-02-02 2002-02-04 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles

Publications (2)

Publication Number Publication Date
NO20033433D0 true NO20033433D0 (no) 2003-08-01
NO20033433L NO20033433L (no) 2003-09-25

Family

ID=23013433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033433A NO20033433L (no) 2001-02-02 2003-08-01 Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol

Country Status (19)

Country Link
US (3) US7129358B2 (no)
EP (2) EP1363901A4 (no)
JP (1) JP2004524303A (no)
KR (1) KR20040029966A (no)
CN (3) CN1876647A (no)
CA (1) CA2436467A1 (no)
CZ (1) CZ20032351A3 (no)
DE (1) DE02706135T1 (no)
ES (1) ES2209678T1 (no)
HR (1) HRP20030691A2 (no)
HU (1) HUP0303144A3 (no)
IS (1) IS6897A (no)
MX (1) MXPA03006904A (no)
NO (1) NO20033433L (no)
PL (1) PL368563A1 (no)
SK (1) SK10792003A3 (no)
WO (1) WO2002062786A1 (no)
YU (1) YU61103A (no)
ZA (1) ZA200305652B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1876647A (zh) 2001-02-02 2006-12-13 特瓦制药工业有限公司 苯并咪唑化合物产品
JP2005533755A (ja) * 2002-03-27 2005-11-10 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール多形及びその調製方法
AU2003268034A1 (en) * 2002-07-26 2004-02-16 Teva Pharmaceutical Industries Ltd. Preparation of lansoprazole and related compounds
JP2006500380A (ja) * 2002-08-21 2006-01-05 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾールの精製方法
AU2003294405A1 (en) * 2002-11-18 2004-06-15 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
US7507829B2 (en) 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
JP2006516574A (ja) * 2003-02-05 2006-07-06 テバ ファーマシューティカル インダストリーズ リミティド ランソプラゾール安定化方法
ES2245277T1 (es) * 2003-03-12 2006-01-01 Teva Pharmaceutical Industries Limited Solidos cristalinos y amorfos de pantoprazol y procedimientos para su preparacion.
MXPA05013316A (es) * 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
DE112005003147T5 (de) 2004-12-16 2008-01-17 Cipla Ltd. Verfahren
EP1681056A1 (en) 2005-01-14 2006-07-19 Krka Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
EP1893602A2 (en) * 2005-05-06 2008-03-05 Medichem, S.A. Pantoprazole free acid form iii
CN1919844B (zh) * 2006-09-01 2010-05-12 武汉工程大学 水相氧化合成兰索拉唑的方法
US20100113527A1 (en) * 2008-09-30 2010-05-06 Teva Pharmaceutical Industries Ltd. Crystalline forms of dexlansoprazole
WO2010134099A1 (en) * 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN108623564B (zh) * 2017-03-17 2022-11-04 江苏豪森药业集团有限公司 一种雷贝拉唑类似物的制备方法
CN111072633A (zh) * 2019-12-19 2020-04-28 山东达因海洋生物制药股份有限公司 一种埃索美拉唑镁三水合物的制备方法
CN112174934B (zh) * 2020-10-15 2023-12-22 成都百泉生物医药科技有限公司 一种奥美拉唑的合成方法及其合成设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
GB2069492B (en) 1980-02-20 1984-02-29 Wyeth John & Brother Ltd Sulphur compounds
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
DK171989B1 (da) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Fremgangsmåde til fremstilling af 2-(2-pyridylmethylsulfinyl)-benzimidazoler
SE9002043D0 (sv) * 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
ES2063705B1 (es) 1993-06-14 1995-07-16 S A L V A T Lab Sa Intermedio para la sintesis de lansoprazol y su procedimiento de obtencion.
SK283805B6 (sk) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Spôsob prípravy omeprazolu
SE9704183D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New process
ATE303809T1 (de) * 1997-12-08 2005-09-15 Altana Pharma Ag Orale verabreichungsform enthaltend einen protonenpumpeninhbitor (z.b. pantoprazole)
GB9805558D0 (en) * 1998-03-17 1998-05-13 Knoll Ag Chemical process`
US6303787B1 (en) * 1998-05-27 2001-10-16 Natco Pharma Limited Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
JP4047993B2 (ja) * 1999-01-04 2008-02-13 理想科学工業株式会社 孔版印刷方法
US6245913B1 (en) * 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
ES2163372B1 (es) * 2000-03-13 2003-05-01 Esteve Quimica Sa Procedimiento de oxidacion de un grupo tioeter a sulfoxido.
CN1876647A (zh) 2001-02-02 2006-12-13 特瓦制药工业有限公司 苯并咪唑化合物产品

Also Published As

Publication number Publication date
CN1781918A (zh) 2006-06-07
NO20033433L (no) 2003-09-25
ZA200305652B (en) 2004-07-22
SK10792003A3 (sk) 2004-07-07
HUP0303144A3 (en) 2007-08-28
PL368563A1 (en) 2005-04-04
CN1489585A (zh) 2004-04-14
ES2209678T1 (es) 2004-07-01
KR20040029966A (ko) 2004-04-08
CZ20032351A3 (cs) 2004-08-18
IS6897A (is) 2003-07-29
US7129358B2 (en) 2006-10-31
US20030036554A1 (en) 2003-02-20
CN1876647A (zh) 2006-12-13
US20060293363A1 (en) 2006-12-28
DE02706135T1 (de) 2004-05-19
US20080091024A1 (en) 2008-04-17
MXPA03006904A (es) 2004-12-06
EP1970374A1 (en) 2008-09-17
HUP0303144A2 (hu) 2004-03-01
EP1363901A4 (en) 2005-08-31
HRP20030691A2 (en) 2005-04-30
JP2004524303A (ja) 2004-08-12
YU61103A (sh) 2006-05-25
WO2002062786A1 (en) 2002-08-15
EP1363901A1 (en) 2003-11-26
CA2436467A1 (en) 2002-08-15
CN100347167C (zh) 2007-11-07

Similar Documents

Publication Publication Date Title
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
NO20033433L (no) Fremgangsmåte for fremstilling av 2-(2-pyridylmetyl)sulfinyl- 1H-benzimidasol
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
DK1380121T3 (da) Fremgangsmåde til fremstilling af oxazolidinoner
NO20030163L (no) Fremgangsmate for fremstilling av olefiner
NO20040278L (no) Fremgangsmate for fremstilling av perindopril
FI20011889A0 (fi) Menetelmä ksylitolin valmistamiseksi
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
EE200300442A (et) Meetod imidasoolühendite valmistamiseks
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
NO20026155D0 (no) Fremgangsmåte for fremstilling av lavere olefiner
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20035136D0 (no) Fremgangsmåte til fremstilling av imipenem
NO20030515L (no) Fremgangsmåte for fremstilling av dinapsolin
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner
FI20010472A0 (fi) Menetelmä alfa-pineenin hydraamiseksi
NO20024887L (no) FremgangsmÕte for fremstilling av benzokondenserte heterosykliske forbindelser
NO20033147L (no) Fremgangsmåte for fremstilling av rent ondansetronhydrogenklorid-dihydrat
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20041193L (no) Fremgangsmåte til fremstilling av beta-ionylidenacetaldehyd
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application